Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Targeting steroid receptor co-activators to inhibit breast cancer stem cells.
Truong TH, Lange CA, Ostrander JH.
Oncoscience. 2018 Aug 28;5(11-12):281-282. doi: 10.18632/oncoscience.469. eCollection 2018 Nov. No abstract available.
Similar articles
RBL2/p130: a direct AKT substrate and mediator of AKT inhibition-induced apoptosis.
Ventura E, Pentimalli F, Giordano A.
Oncoscience. 2018 Aug 28;5(11-12):278-280. doi: 10.18632/oncoscience.467. eCollection 2018 Nov. No abstract available.
Coaching tumor-infiltrating CD8+ T cells to eat right.
Kurupati R, Ertl HC.
Oncoscience. 2018 Aug 24;5(11-12):276-277. doi: 10.18632/oncoscience.466. eCollection 2018 Nov. No abstract available.
N-MYC regulation of DNA damage response in neuroendocrine prostate cancer: mechanistic insight and novel combination therapy approaches.
Thompson TC, Liu B, Li L.
Oncoscience. 2018 Aug 22;5(11-12):273-275. doi: 10.18632/oncoscience.462. eCollection 2018 Nov. No abstract available.
Origins of ETP leukemia.
Booth CAG, Jacobsen SEW, Mead AJ.
Oncoscience. 2018 Aug 22;5(11-12):271-272. doi: 10.18632/oncoscience.456. eCollection 2018 Nov. No abstract available.
M7824: A promising new strategy to combat cancer immune evasion.
Gatti-Mays ME, Gulley JL.
Oncoscience. 2018 Aug 22;5(11-12):269-270. doi: 10.18632/oncoscience.451. eCollection 2018 Nov. No abstract available.
Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.
Galván DC, Ayyappan AP, Bryan BA.
Oncoscience. 2018 Oct 11;5(9-10):264-268. doi: 10.18632/oncoscience.472. eCollection 2018 Sep.
Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018).
Díaz-Martínez M, Benito-Jardón L, Alonso L, Teixidó J.
Oncoscience. 2018 Nov 9;5(9-10):262-263. doi: 10.18632/oncoscience.473. eCollection 2018 Sep. No abstract available.
ETV4: an emerging target in pancreatic cancer.
Deshmukh SK, Singh AP, Singh S.
Oncoscience. 2018 Oct 11;5(9-10):260-261. doi: 10.18632/oncoscience.471. eCollection 2018 Sep. No abstract available.
TP53 mutation status: emerging biomarker for precision radiation medicine?
Willers H, Wang M, Benes CH.
Oncoscience. 2018 Aug 28;5(9-10):258-259. doi: 10.18632/oncoscience.468. eCollection 2018 Sep. No abstract available.
Risks and chances of aberrant DNA repair in cancer.
Schubert M, Greil R, Geisberger R.
Oncoscience. 2018 Aug 22;5(9-10):256-257. doi: 10.18632/oncoscience.459. eCollection 2018 Sep. No abstract available.
Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance.
Chauhan SS, Warfel NA.
Oncoscience. 2018 Aug 22;5(9-10):254-255. doi: 10.18632/oncoscience.458. eCollection 2018 Sep. No abstract available.
Re-thinking preclinical models of cancer metastasis.
Ullo MF, Logue JS.
Oncoscience. 2018 Aug 22;5(9-10):252-253. doi: 10.18632/oncoscience.450. eCollection 2018 Sep. No abstract available.
Biological role of miR-204 and miR-211 in melanoma.
Vitiello M, D'Aurizio R, Poliseno L.
Oncoscience. 2018 Aug 22;5(7-8):248-251. doi: 10.18632/oncoscience.443. eCollection 2018 Jul.
A survey of current surgical treatment of early stage breast cancer in China.
Zhang X, Wang Y.
Oncoscience. 2018 Aug 22;5(7-8):239-247. doi: 10.18632/oncoscience.445. eCollection 2018 Jul.
Docetaxel increases the risk of severe infections in the treatment of non-small cell lung cancer: a meta-analysis.
Du Q, Jiang G, Li S, Liu Y, Huang Z.
Oncoscience. 2018 Aug 22;5(7-8):220-238. doi: 10.18632/oncoscience.444. eCollection 2018 Jul.
BCL-2 inhibition is a promising therapeutic strategy for small cell lung cancer.
Lochmann TL, Bouck YM, Faber AC.
Oncoscience. 2018 Aug 14;5(7-8):218-219. doi: 10.18632/oncoscience.455. eCollection 2018 Jul. No abstract available.
Proteomics of prostate cancer - revealing how cancer cells master their messy genomes.
Latonen L, Nykter M, Visakorpi T.
Oncoscience. 2018 Jul 31;5(7-8):216-217. doi: 10.18632/oncoscience.453. eCollection 2018 Jul. No abstract available.
Attenuation of YAP1 can potentially target cancer stem cells to overcome drug resistance.
Harada K, Song S, Ajani JA.
Oncoscience. 2018 Aug 22;5(7-8):214-215. doi: 10.18632/oncoscience.449. eCollection 2018 Jul. No abstract available.
Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome.
Wang H, Zhuang Z, Chan CC.
Oncoscience. 2018 Aug 22;5(7-8):212-213. doi: 10.18632/oncoscience.447. eCollection 2018 Jul. No abstract available.
Filters: Manage Filters